Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Improving diagnostic molecular tests to monitor urothelial carcinoma recurrence.

Expert review of molecular diagnostics - 1 Nov 2016

Krabbe Laura-Maria, Woldu Solomon L, Shariat Shahrokh F, Lotan Yair

Abstract excerpt

INTRODUCTION: The high recurrence rates associated with non-muscle invasive bladder cancer require close surveillance with cystoscopy, an invasive and expensive procedure with risk of missing cancer. Finding an accurate urinary biomarker that can detect recurrent disease would represent a significant advancement in management. Areas covered: This review summarizes the commercially-available urinary biomarkers...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma
Share to Cytological Techniques
Share to Disease Management

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Early Detection of Cancer

Share to Epigenomics

Share to Metabolomics

Share to Molecular Diagnostic Techniques

Share to Neoplasm Recurrence, Local

Source

Identifiers

PMID: 27696932
DOI: 10.1080/14737159.2016.1244006

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Improving diagnostic molecular tests to monitor urothelial carcinoma recurrence.PMID 27696932Read ↗

Urinary Biomarkers in Bladder Cancer: FDA-Approved Tests and Emerging Tools for Diagnosis and SurveillanceSemantic proximity Read ↗

Performance Characteristics of a Multigene Urine Biomarker Test for Monitoring for Recurrent Urothelial Carcinoma in a Multicenter StudySemantic proximity Read ↗

Urinary Biomarkers in Urothelial Carcinoma: Expanded Con-temporary Evidence for Diagnosis, Surveillance, Risk Stratification, and Cystoscopy-Sparing Clinical PathwaysSemantic proximity Read ↗

Uromonitor®: Clinical Validation and Performance Assessment of a Urinary Biomarker for Recurrence Surveillance in Non-Muscle Invasive Bladder Cancer PatientsSemantic proximity Read ↗

Current and emerging bladder cancer biomarkers with an emphasis on urine biomarkersSemantic proximity Read ↗

Trends in urine biomarker discovery for urothelial bladder cancer: DNA, RNA, or protein?Semantic proximity Read ↗

A systematic review on diagnostic and prognostic biomarkers for bladder cancerSemantic proximity Read ↗

Uromonitor <sup>®</sup> as a novel sensitive and specific urine-based test for recurrence surveillance of patients with non-muscle invasive bladder cancerSemantic proximity Read ↗

Molecular markers for detection, surveillance and prognostication of bladder cancer.Semantic proximity Read ↗

Uromonitor: Clinical Validation and Performance Assessment of a Urinary Biomarker Within the Surveillance of Patients With Nonmuscle-Invasive Bladder Cancer.Semantic proximity Read ↗

Diagnostic Test Accuracy of Commercially Available Tests for The Recurrence of Bladder Cancer: A Systematic Review and Meta-AnalysisSemantic proximity Read ↗

A urinary assay for mutation and methylation biomarkers in the diagnosis and recurrence prediction of non-muscle invasive bladder cancer patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.